Insider Transaction Report for David J. Wambeke

David J. Wambeke, Chief Business Officer at NEUROONE MEDICAL TECHNOLOGIES Corp, reported a series of transactions on August 27-28, 2026. He acquired 33,333 shares of Common Stock at a weighted average price of $2.01 per share, with individual transactions ranging from $2.00 to $2.017. Following this, he was granted an option to purchase 35,000 shares of Common Stock at an exercise price of $1.77, with vesting commencing on August 28, 2027. These transactions indicate a significant increase in Wambeke's holdings and potential future ownership in the company.